Julio Cesar Cardenas

8PUBLICATIONS
35CO-AUTHORS
Molecular targetsHaematological tumoursNeurology and neuromuscular diseasesNuclear engineering (incl. fuel enrichment and waste processing and storage)Cellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 21, 2025
Calcium (Ca<sup>2+</sup>) fluxes at mitochondria-ER contact sites (MERCS) are a new target of senolysis in therapy-induced senescence (TIS).

Andrea Puebla-Huerta, Hernán Huerta, Camila Quezada-Gutierez

|May 10, 2024
Novel Inositol 1,4,5-Trisphosphate Receptor Inhibitor Antagonizes Hepatic Stellate Cell Activation: A Potential Drug to Treat Liver Fibrosis.

Natalia Smith-Cortinez, Janette Heegsma, Masa Podunavac

|Mar 28, 2023
Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenation.

Macarena S Arrázola, Matías Lira, Felipe Véliz-Valverde

|Jul 20, 2022
Balancing energy and protein homeostasis at ER-mitochondria contact sites.

Amado Carreras-Sureda, Guido Kroemer, Julio Cesar Cardenas

|Dec 24, 2021
Directly Reprogrammed Human Neurons to Understand Age-Related Energy Metabolism Impairment and Mitochondrial Dysfunction in Healthy Aging and Neurodegeneration.

Camila Gudenschwager, Isadora Chavez, Cesar Cardenas

|Jan 14, 2021
Inhibition of InsP3R with Xestospongin B Reduces Mitochondrial Respiration and Induces Selective Cell Death in T Cell Acute Lymphoblastic Leukemia Cells.

Pablo Cruz, Ulises Ahumada-Castro, Galdo Bustos

Pageof 2

Frequent Collaborators

2 joint publications

Alenka Lovy

2 joint publications

Galdo Bustos

2 joint publications

Fabian Jaňa

2 joint publications

Hernan Huerta